MedTrace Logo

Neuromuscular Blockade for Post-Cardiac Arrest Care

NCT02260258 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2021-01-29

Study results available
· View outcomes & findings →

Summary

The main purpose of this study is to evaluate if neuromuscular blockade improves lactate clearance (and preliminary secondary clinical outcome measures) as compared to usual care in post-cardiac arrest patients undergoing targeted temperature management.

Conditions

  • Cardiac Arrest

Interventions

DRUG

Rocuronium

Neuromuscular Blockade

DRUG

Normal Saline

Normal Saline

Sponsors & Collaborators

  • University of Pittsburgh Medical Center

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Beaumont Hospital

    collaborator OTHER

  • Beth Israel Deaconess Medical Center

    lead OTHER

Principal Investigators

  • Michael W Donnino, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2019-05-29
Completion
2019-05-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02260258 on ClinicalTrials.gov